Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785]

K Van Baelen¹, T Geukens², M Maetens³, V Tjan-Heijnen⁴, C J Lord⁵, S Linn⁶, F-C Bidard⁷, F Richard³, W W Yang⁵, R E Steele⁵, S J Pettitt⁵, C Van Ongeval⁸, M De Schepper⁹, E Isnaldi³, I Nevelsteen¹⁰, A Smeets¹⁰, K Punie¹¹, L Voorwerk¹², H Wildiers¹¹, G Floris¹³, A Vincent Salomon¹⁴, P W B Derksen¹⁵, P Neven¹⁶, E Senkus¹⁷, E Sawyer¹⁸, M Kok¹², C Desmedt¹⁹

Affiliations

¹ Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven; Department of Gynaecology and Obstetrics, UZ Leuven, Leuven, Belgium.
² Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven; Department of General Medical Oncology, UZ Leuven, Leuven, Belgium.
³ Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven.
⁴ Department of Medical Oncology Department, Maastricht University Medical Center (MUMC), School of GROW, Maastricht, The Netherlands.
⁵ The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
⁶ Department of Pathology, University Medical Center Utrecht, Utrecht; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁷ Department of Medical Oncology, Institut Curie, UVSQ/Paris-Saclav University, Paris, France.
⁸ Department of Radiology, UZ Leuven, Leuven, Belgium.
⁹ Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven; Department of Pathology, UZ Leuven, Leuven, Belgium.
¹⁰ Department of Surgical Oncology, UZ Leuven, Leuven, Belgium.
¹¹ Department of General Medical Oncology, UZ Leuven, Leuven, Belgium.
¹² Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Tumour Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹³ Department of Pathology, UZ Leuven, Leuven, Belgium.
¹⁴ Department of Pathology, Institut Curie, Paris, France.
¹⁵ Department of Pathology, University Medical Center Utrecht, Utrecht.
¹⁶ Department of Gynaecology and Obstetrics, UZ Leuven, Leuven, Belgium.
¹⁷ Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.
¹⁸ School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
¹⁹ Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven. Electronic address: christine.desmedt@kuleuven.be.

PMID: 36529568
DOI: 10.1016/j.annonc.2022.11.010

Free article

Published Erratum

Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785]

K Van Baelen et al. Ann Oncol. 2023 Mar.

Free article

. 2023 Mar;34(3):326.

doi: 10.1016/j.annonc.2022.11.010. Epub 2022 Dec 16.

Authors

Affiliations

¹ Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven; Department of Gynaecology and Obstetrics, UZ Leuven, Leuven, Belgium.
² Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven; Department of General Medical Oncology, UZ Leuven, Leuven, Belgium.
³ Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven.
⁴ Department of Medical Oncology Department, Maastricht University Medical Center (MUMC), School of GROW, Maastricht, The Netherlands.
⁵ The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
⁶ Department of Pathology, University Medical Center Utrecht, Utrecht; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁷ Department of Medical Oncology, Institut Curie, UVSQ/Paris-Saclav University, Paris, France.
⁸ Department of Radiology, UZ Leuven, Leuven, Belgium.
⁹ Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven; Department of Pathology, UZ Leuven, Leuven, Belgium.
¹⁰ Department of Surgical Oncology, UZ Leuven, Leuven, Belgium.
¹¹ Department of General Medical Oncology, UZ Leuven, Leuven, Belgium.
¹² Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Tumour Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹³ Department of Pathology, UZ Leuven, Leuven, Belgium.
¹⁴ Department of Pathology, Institut Curie, Paris, France.
¹⁵ Department of Pathology, University Medical Center Utrecht, Utrecht.
¹⁶ Department of Gynaecology and Obstetrics, UZ Leuven, Leuven, Belgium.
¹⁷ Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.
¹⁸ School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK.
¹⁹ Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven. Electronic address: christine.desmedt@kuleuven.be.

PMID: 36529568
DOI: 10.1016/j.annonc.2022.11.010

No abstract available

PubMed Disclaimer

Erratum for

Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
Van Baelen K, Geukens T, Maetens M, Tjan-Heijnen V, Lord CJ, Linn S, Bidard FC, Richard F, Yang WW, Steele RE, Pettitt SJ, Van Ongeval C, De Schepper M, Isnaldi E, Nevelsteen I, Smeets A, Punie K, Voorwerk L, Wildiers H, Floris G, Vincent-Salomon A, Derksen PWB, Neven P, Senkus E, Sawyer E, Kok M, Desmedt C. Van Baelen K, et al. Ann Oncol. 2022 Aug;33(8):769-785. doi: 10.1016/j.annonc.2022.05.006. Epub 2022 May 21. Ann Oncol. 2022. PMID: 35605746 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785]

Affiliations

Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources